COVID Vaccine Booster Available at JPS for Certain High-Risk Groups
The FDA has authorized an additional dose (booster) of both the Pfizer-BioNTech and Moderna COVID-19 vaccines in certain immunocompromised individuals. JPS will begin offering this additional dose to patients and team members who meet the following criteria or are evaluated to have an equal level of health risk: